Y Murai
Overview
Explore the profile of Y Murai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
286
Citations
747
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Murai Y, Murai Y, Nagaoka K, Nagaoka K, Iwanaga N, Iwanaga N, et al.
Int J Infect Dis
. 2025 Feb;
153:107840.
PMID: 39929321
Objectives: Routine clinical practice with extended anaerobic antibiotic coverage (EAC) has been recently reconsidered for several infections; however, its benefits remain unclear even in patients with anaerobic bacteremia (AB). Here,...
2.
Nagaoka K, Iwanaga N, Takegoshi Y, Murai Y, Kawasuji H, Miura M, et al.
Eur J Clin Microbiol Infect Dis
. 2024 Jan;
43(3):459-467.
PMID: 38172403
Purpose: During the last decade, the incidence of anaerobic bacteremia (AB) has been increasing. Patients with AB may develop complex underlying diseases, which can occasionally be accompanied by fatal or...
3.
Nagaoka K, Kawasuji H, Takegoshi Y, Murai Y, Kaneda M, Kimoto K, et al.
Front Immunol
. 2023 Sep;
14:1197436.
PMID: 37731495
Background: Immune response indicators in the early phase of COVID-19, including interferon and neutralizing responses against SARS-CoV-2, which predict hypoxemia remains unclear. Methods: This prospective observational study recruited patients hospitalized...
4.
Nagaoka K, Kawasuji H, Takegoshi Y, Murai Y, Kaneda M, Ueno A, et al.
Eur Radiol
. 2023 Feb;
33(7):4713-4722.
PMID: 36735038
Objectives: To examine the radiological patterns specifically associated with hypoxemic respiratory failure in patients with coronavirus disease (COVID-19). Methods: We enrolled patients with COVID-19 confirmed by qPCR in this prospective...
5.
Takahashi M, Okada K, Ouch R, Konno T, Usui K, Suzuki H, et al.
Pharmazie
. 2022 Jan;
76(12):594-601.
PMID: 34986955
Resistance to lenvatinib mesylate (LEN), a systemic chemotherapy that can be administered orally, has been a major issue for treatment of hepatocellular carcinoma (HCC). Although HCC is the tumor that...
6.
Ishisaka E, Morita A, Murai Y, Tsukiyama A
Neurochirurgie
. 2021 Apr;
67(5):450-453.
PMID: 33915149
Objectives: It was reported that the XYZ/2 technique (using length, width and height of hematoma) is a simple and reliable method of estimation of chronic subdural hematoma volume. Two subtypes...
7.
Murai Y, Okabe Y, Tanaka E
J Neurophysiol
. 2012 Feb;
107(9):2517-25.
PMID: 22323633
Intracellular recordings were made from rat hippocampal CA1 neurons in rat brain slice preparations to investigate whether cAMP-dependent protein kinase (PKA) and calcium/phospholipid-dependent protein kinase C (PKC) contribute to the...
8.
Tomiyama J, Kudo H, Nakamura N, Murai Y, Tsunadori S, Muto Y, et al.
Oncol Rep
. 2011 May;
2(4):669-73.
PMID: 21597796
From January 1989 until December 1992, 120 elderly patients over 65 years old with multiple myeloma (MM) were enrolled with the Elderly Hematology Study Group (EHSG) with 14 institutions participating....
9.
Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Miwa S, et al.
Br J Cancer
. 2006 Nov;
95(10):1371-8.
PMID: 17088917
Tumour growth depends on angiogenesis, which is closely associated with vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs). Extracellular MMP inducer (EMMPRIN) was reported to involve in the progression...
10.
Nomoto K, Tsuneyama K, Abdel Aziz H, Takahashi H, Murai Y, Cui Z, et al.
J Pathol
. 2006 Oct;
210(4):469-77.
PMID: 17029217
Galectin-3, a beta-galactoside-binding animal lectin, is a multifunctional protein. Previous studies have suggested that galectin-3 may play an important role in inflammatory responses. Non-alcoholic fatty liver disease (NAFLD) is increasingly...